Nvidia-backed AI drug developer Iambic is raising $150 million in U.S. IPO
- U.S. IPO 近 90 天出现 7 次
- 上一次：5 天前 · City Therapeutics is seeking up to $185 million in a U.S. IPO for its gene-silencing drugs
发生了什么
The San Diego company's stock is expected to begin trading on Nasdaq Thursday under the ticker IAM, with the offering expected to close Friday
摘要按规则整理自下方来源原文